@Jlivermore - I went to the yahoo board and read the posts. It encouraging to see people talking about the stock. Different opinions, cross currents are a healthy part of investment. It is easy to get distracted by the noise. Negatives post propagate fear.
Different people have different matrix to evaluation a fair stock price. "Stock" on the yahoo board uses stock price/earnings and comes to the conclusion the price is too high. I am more concerned that the stock price has dramatically appreciated since(because of?) the Craig Hallum buy recommendation. And there is space underneath.
On the yahoo board, I find Chris's reply to Stock's post more inline with my assessment of RMS, "While they may not have introduced relevant "new" products the pharmaceutical industry is moving towards RMS Medical's products on multiple fronts. Big pharma wants subq products to elongate patent production. Patients want sub-q for ease of use and convenience Payers like sub-q as it cuts costs. Growing at 20% with eye on 70% margins. Room in my portfolio for REPR. A lot of room."
I would add that there is nothing sexy about the Freedom pump. It is dependable, easy to use and cost effective. I would choose those attributes in a medical device over sexy any day.
Tuesday end of the day trading looked spasmatic. I attribute that to the wide bid/ask gap and market makers prior to uplisting.
News 
Market Data 
Discover 
